Evidence map›Paper›PMID 38690004›Full record

ArticleHealth science reports2024

Antimicrobial combination effects against multidrug-resistant

Hossein Kazemian, Morteza Karami-Zarandi, Hamid Heidari, Roya Ghanavati, Saeed Khoshnood

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Health science reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Antimicrobial potential of compounds from the MMV pandemic response box and COVID box against carbapenem-resistant Acinetobacter baumannii.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2025
    Article
  2. Cefiderocol-Based Regimen for Acinetobacter NDM-1 Outbreak.Antibiotics (Basel, Switzerland) · 2024
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Hossein KazemianClinical Microbiology Research Center Ilam University of Medical Sciences Ilam Iran.ORCID 0000-0003-4590-396X
Morteza Karami-ZarandiDepartment of Microbiology, Faculty of Medicine Zanjan University of Medical Sciences Zanjan Iran.
Hamid HeidariDepartment of Microbiology, Faculty of Medicine Shahid Sadoughi University of Medical Sciences Yazd Iran.ORCID 0000-0002-6869-2301
Roya GhanavatiSchool of Paramedical Sciences Behbahan Faculty of Medical Sciences Behbahan Iran.
Saeed KhoshnoodClinical Microbiology Research Center Ilam University of Medical Sciences Ilam Iran.ORCID 0000-0002-5143-3178
Medical University of Ilam · IRShahid Sadoughi University of Medical Sciences and Health Services · IRZanjan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aims: Emergence of multidrug resistance in non-fermenting Gram-negative bacilli is a threat to public health. Combination therapy is a strategy for the treatment of antibiotic-resistant infections. Methods: In this cross-sectional study, a total of 63 nonduplicate clinical isolates of Results: For Conclusion: The MER-TIG and COL-MER combinations are promising options against resistant bacteria. Our study could be helpful for the development of a new treatment recommendation.

Indexed as

Acinetobacter baumanniidrug resistancedrug synergismPseudomonas aeruginosa

Identifiers

PMID38690004
PMCPMC11058283
OpenAlexW4396561064

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.